NovoBind is a biotechnology company focused on developing novel solutions to combat pathogens in livestock and aquaculture through precision biology. Their approach aims to improve animal health, productivity, and food safety without the use of antibiotics, thereby contributing to a more sustainable food supply.

NovoBind

Eilean Therapeutics is a small molecule oncology drug discovery company that develops pan-variant therapies for hematologic malignancies targeting major drivers of cancer resistance.

Eilean Therapeutics

NOVOBIOM provides innovative solutions for the ecological clean-up of heavily polluted natural resources. Relying on an innovative biotechnology platform and rupturing from the usual industrial practices, we enlarge the scope of existing techniques with a novel biological solution (Mycoremediation) for the treatment of contaminated waste. Currently focusing on tackling soil contamination, we introduce within the industry an efficient and competitive new way to managing and rehabilitating heavily contaminated industrial waste.

As future generations deserve to thrive on a clean planet with healthy soils, our mission is to solve current environmental and societal challenges by developing bio-inspired restorative innovations.

Novobiom

🎉 Caroline Zaoui, PhD, co-fondatrice et directrice scientifique de l’entreprise wallonne Novobiom, est l’une des lauréates du prix #WomenTechEU. 🏆 

▶ Elle explique comment le NCP Wallonie l'a aidée à décrocher cette distinction:  "Pour décrocher des financements européens, le NCP Wallonie permet de faire la différence."

Témoignage et "success story" à découvrir ici ⬇ 

https://lnkd.in/ekbsfr7U


📣 Our project #INNO4CFIs promoting #innovation for #carbonfarming is kick-starting! 

🧑‍💼 The consortium of 14 expert partners led by Fondazione E. Amaldi spanning 8 European countries gathered for the project start in #Rome, Italy in September. 

#INNO4CFIs, co-funded by the #EuropeanRegionalDevelopmentFund #I3instrument, is redefining #carbonfarming and #greentechnologies. 

With a focus on carbon farming initiatives and #reforestation, the aim is to increase #CO2 uptake while nurturing vital #environmental benefits like freshwater production, soil restoration, and biodiversity enhancement. 📈

Throughout the next 3 years, this ambitious project will develop a #CarbonFarmingTechnology platform for innovative nature-based solutions that support carbon removal practices and enhance #climateadaptation. 🌍

🤝 We are excited to blend innovation and expertise to pave the way for a greener, more prosperous future with our colleagues from Fondazione E. Amaldi #Planet Treedom Space4Good Consiglio Nazionale delle Ricerche F6S AB Corporation National Technical University of Athens AINIA Novobiom 🌱 TREEO 🌱 Cooling the planet #Rancho 

Stay tuned for updates! 

#sustainability #greentech #naturebasedsolutions #EUinnovation #ERDF #circulareconomy #climateaction #climatesolution #biodiversity #environment

Metric
Company Name	NovoBind	Eilean Therapeutics
Symbol
MSH ID	COM:NOVOBIOM	COM:EILEANTHER
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Agricultural Biotechnology	Biotechnology
Country	BE	US
Stage
Employee Count	9
Website	novobiom.com	eileanther.com
LinkedIn	novobiom
Founders

Metric
Market Cap	139.92M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NOVOBIOM

NovoBind

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue